Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ('SEBI Listing Regulations') this is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 17, 2024, inter-alia, considered and approved the following matters:- (i) Financial Results (ii) Dividend (iii) Re-appointment of Directors (iv) Appointment of Auditors (v) Appointment of Company Secretary and Compliance officer This is for your information and record please.

pdf

Fortis Malar Hospitals Ltd.

16 May 2024

66.01

-0.50%

Corp. Note

Fortis Malar Hospitals Limited - 523696 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation for loss of share certificates pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015.

pdf

Fortis Malar Hospitals Ltd.

10 May 2024

66.01

-0.50%

Board Meeting

Fortis Malar Hospitals Limited - 523696 - Board Meeting Intimation for Notice Of Board Meeting Under …

BSE India

Fortis Malar Hospitals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve In pursuance of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, May 17, 2024 to inter-alia, consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2024. Further, in continuation to our reference letter FMHL/SEC/MAR'2024 dated March 27, 2024 with respect to the 'Closure of Trading Window', it is hereby informed that the 'Trading Window' for dealing in the Company's Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto May 19, 2024. This is for your information and record please.

pdf

Fortis Malar Hospitals Ltd.

01 May 2024

66.01

-0.50%

Company Update

Fortis Malar Hospitals Limited - 523696 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

The Company has appointed Mr. Ramesh L. Adige as Non Executive Non-Independent Director of the Company with effect from May 6, 2024, the detailed disclosure is enclosed.

pdf

Fortis Malar Hospitals Ltd.

01 May 2024

66.01

-0.50%

Company Update

Fortis Malar Hospitals Limited - 523696 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

The Company has appointed Mr. Ramesh L. Adige as Non Executive Non Independent Director of the Company with effect from May 6, 2024, the detailed disclosure is enclosed.

pdf

Fortis Malar Hospitals Ltd.

22 Apr 2024

66.01

-0.50%

Corp. Note

Fortis Malar Hospitals Limited - 523696 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFortis Malar Hospitals Limited 2CIN NO.L85110PB1989PLC045948 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Please refer detailed disclosure Designation: Company Secretary EmailId: secretarial.malar@malarhospitals.in Name of the Chief Financial Officer: Yogendra Kumar Kabra Designation: Chief Financial Officer EmailId: secretarial.malar@malarhospitals.in Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Fortis Malar Hospitals Ltd.

22 Apr 2024

66.01

-0.50%

Company Update

Fortis Malar Hospitals Limited - 523696 - PCS Certificate Under Regulation 40(10) Of SEBI Listing Regulations, …

BSE India

Please find the enclosed PCS Certificate as per Regulation 40(10) of SEBI LODR Regulations, 2015

pdf

Fortis Malar Hospitals Ltd.

18 Apr 2024

66.01

-0.50%

Company Update

Fortis Malar Hospitals Limited - 523696 - Announcement under Regulation 30 (LODR)-Open Offer - Updates

BSE India

A detailed disclosure with respect to adjustment of open offer price of the company is attached.

pdf

Fortis Malar Hospitals Ltd.

18 Apr 2024

66.01

-0.50%

Company Update

Fortis Malar Hospitals Limited - 523696 - Updates on Open Offer (Corrigendum)

BSE India

HSBC Securities and Capital Markets (India) Private Limited, HDFC Bank Limited, Citigroup Global Markets India Private Limited and Deutsche Equities India Private Limited ('Managers to the Open Offer') has submitted to BSE a copy of Corrigendum to the detailed Public Statement dated November 19, 2018 with respect to the Open Offer to the Public Shareholders of Fortis Malar Hospitals Ltd ("Target Company").

pdf

Is Fortis Malar Hospitals Ltd. worth buying?

148 Votes:

Buy 64.19%

Sell 22.3%

Hold 13.51%